Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial
- 28 September 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (4) , 1239-1244
- https://doi.org/10.1016/s0735-1097(00)00882-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Intermittent ClaudicationCirculation, 1997
- Basic Fibroblast Growth Factor Increases Collateral Blood Flow in Rats With Femoral Arterial LigationCirculation Research, 1996
- Epidemiology of Peripheral Arterial DiseaseJournal of Cardiovascular Pharmacology, 1994
- Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth FactorScience, 1992
- Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factorJournal of Vascular Surgery, 1992
- bFGF enhances the development of the collateral circulation after acute arterial occlusionBiochemical and Biophysical Research Communications, 1992
- Peripheral vascular disease: a public health perspective *Journal of Public Health, 1990
- Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965‐1985 [see comments]British Journal of Clinical Pharmacology, 1988
- The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population.Circulation, 1985
- The measurement of volume changes in human limbsThe Journal of Physiology, 1953